Avicanna has announced that through its majority-owned subsidiary Santa Marta Golden Hemp SAS the Company completed the first export of non-psychoactive CBD dominant cannabis flower to Switzerland.
This export is a result of improvements directed by the Company in 2024, when it improved internal practices and enhanced the local infrastructure at SMGH to expand the portfolio of Aureus branded products with premium organic flower to meet the growing demand of medical cannabis flower in Europe and Australia. The Company is currently producing a range of proprietary and premium CBD, CBG and THC genetics for these markets.
This export included three proprietary varieties which are a part of the Company's portfolio of registered cannabis varieties in Colombia. This also marks the 20th international market for Aureus-branded products and 23rd market for all Avicanna products which further validates the Company's expertise in navigating complex regulatory processes for its commercialization efforts internationally.
For more information:
Avicanna
[email protected]
www.avicanna.com
